Q848S6 (BLKPC_KLEOX) Klebsiella oxytoca

Carbapenem-hydrolyzing beta-lactamase KPC UniProtKBInterProInteractive Modelling

293 aa; Sequence (Fasta) ; 66 identical sequences

Available Structures

74 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP)
3e2l
 Heteromer
P35804; Q9F663; 		30-290
Assess
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP)
3e2k
 Heteromer
P35804; Q9F663; 		30-290
Assess
Acyl-enzyme complex of cephalothin bound to deacylation mutant KPC-2 (E166Q)
8akj
homo-2-mer25-292
6×SO4; 6×GOL; 2×CEO;
Assess
Apo KPC-2 beta-lactamase crystal structure at 1.15 Angstrom resolution
5ul8
monomer25-293
4×SO4; 1×GOL;
Assess
Apo KPC-2 N170A mutant at 1.20 A
6xd5
monomer25-293
1×GOL; 4×SO4;
Assess
Structure of KPC-2 bound to Vaborbactam at 1.25 A
6v7i
monomer25-293
1×4D6; 4×SO4; 1×GOL;
Assess
Structure of KPC-2 bound to QPX7728 at 1.30 A
6v1j
monomer25-293
1×RM9; 1×QNA; 1×GOL; 2×SO4;
Assess
Crystal structure of vaborbactam bound to KPC-2
6td0
monomer25-292
1×4D6; 2×GOL; 5×SO4;
Assess
Crystal structure of KPC-4 complexed with relebactam (16 hour soak)
6qwb
monomer25-292
4×SO4; 1×JJT; 1×GOL; 1×MK7;
Assess
Crystal structure of KPC-2 complexed with relebactam (16 hour soak)
6qw9
monomer25-292
3×SO4; 1×GOL; 1×MK7; 1×JJT;
Assess
Crystal structure of KPC-3 complexed with relebactam (16 hour soak)
6qwa
monomer25-292
2×SO4; 1×GOL; 1×EOH; 1×MK7; 1×JJT;
Assess
Crystal structure of VNRX-5133 (taniborbactam) bound to KPC-2
6td1
monomer25-292
1×GOL; 1×KJK; 2×SO4;
Assess
Crystal structure of KPC-3
6qwd
monomer25-292
5×SO4; 2×GOL;
Assess
Acylenzyme complex of ceftazidime bound to deacylation mutant KPC-4 (E166Q)
6z25
monomer25-292
4×GOL; 1×CAZ; 5×SO4;
Assess
Acyl-enzyme complex of ertapenem bound to deacylation mutant KPC-2 (E166Q)
8akm
monomer25-292
4×SO4; 1×GOL; 1×N9X;
Assess
Acylenzyme complex of ceftazidime bound to deacylation mutant KPC-2 (E166Q)
6z24
monomer25-292
1×CAZ; 3×SO4;
Assess
Crystal structure of KPC-2 with hydrolyzed faropenem (ring-open form)
7a61
monomer25-292
1×R0B; 2×GOL; 4×SO4;
Assess
Crystal structure of KPC-4 complexed with relebactam (1 hour soak)
6qwc
monomer25-292
8×SO4; 1×GOL; 1×MK7;
Assess
Crystal structure of KPC-2 complexed with compound 1
6d15
monomer25-292
2×TWB; 1×GOL;
Assess
Crystal structure of deacylation mutant KPC-2 (E166Q)
6z21
monomer25-292
2×GOL; 6×SO4; 1×CL;
Assess
Acylenzyme complex of cefotaxime bound to deacylation mutant KPC-2 (E166Q)
6z23
monomer25-292
2×GOL; 5×SO4; 1×CEF;
Assess
Acyl-enzyme complex of meropenem bound to deacylation mutant KPC-2 (E166Q)
8akl
monomer25-292
1×GOL; 1×O2F; 4×SO4;
Assess
Crystal structure of KPC-2 complexed with compound 6
6d18
monomer25-292
3×GTV; 1×GOL;
Assess
Acyl-enzyme complex of imipenem bound to deacylation mutant KPC-2 (E166Q)
8akk
monomer25-292
1×ID1; 1×HIW; 3×SO4; 2×GOL;
Assess
Crystal structure of deacylation mutant KPC-4 (E166Q)
6z22
monomer25-292
4×SO4; 1×GOL;
Assess
Crystal structure of KPC-4
6qwe
monomer25-292
3×SO4; 2×GOL;
Assess
Acyl-enzyme complex of ampicillin bound to deacylation mutant KPC-2 (E166Q)
8aki
monomer25-292
1×AIX; 4×SO4; 1×GOL;
Assess
Crystal structure of KPC-2 complexed with compound 2
6d16
monomer25-292
1×FUJ; 1×GOL;
Assess
Crystal structure KPC-2 beta-lactamase complexed with WCK 4234 by soaking
6b1f
monomer22-289
1×C8Y; 1×CIT; 1×EDO;
Assess
Crystal structure of KPC-2 complexed with compound 9
6d19
monomer25-292
3×YKG; 1×GOL;
Assess
Crystal structure KPC-2 beta-lactamase complexed with WCK 5153 by soaking
6b1x
monomer22-289
1×C9D; 1×CIT; 5×EDO;
Assess
Crystal structure of KPC-2 complexed with compound 3
6d17
monomer25-292
1×VKE; 1×GOL;
Assess
Crystal structure KPC-2 beta-lactamase complexed with WCK 5107 by soaking
6b1j
monomer22-289
1×C8V; 3×CIT; 6×EDO;
Assess
Crystal structure KPC-2 beta-lactamase complexed with WCK 5107 by co-crystallization
6b1w
monomer22-289
2×SO4; 1×CL; 1×C8V;
Assess
Crystal structure KPC-2 beta-lactamase complexed with WCK 4234 by co-crystallization
6b1h
monomer22-289
1×C8Y; 1×SO4; 1×CL; 1×ACT;
Assess
Crystal structure KPC-2 beta-lactamase complexed with WCK 5153 by co-crystallization
6b1y
monomer22-289
1×CD7; 2×SO4; 1×CL;
Assess
Crystal structure of indoline 9 with KPC-2
7ua7
monomer25-292
3×GOL; 1×M53;
Assess
Crystal structure of the KPC-2 beta-lactamase complexed with hydrolyzed cefotaxime
5uj3
monomer25-291
2×CE4; 1×GOL;
Assess
Crystal structure of indoline 7 with KPC-2
7u9b
monomer25-291
1×M2I;
Assess
Crystal structure of the KPC-2 beta-lactamase complexed with hydrolyzed faropenem
5uj4
monomer25-290
1×SFR; 1×GOL;
Assess
KPC-2 N170A mutant bound to hydrolyzed ampicillin at 1.65 A
6xd7
monomer25-290
1×ZZ7; 1×GOL;
Assess
Crystal structure of KPC-2 with compound 3
6m7i
monomer25-290
4×J84; 1×GOL;
Assess
Crystal structure of KPC-2 with compound 6
6mnp
monomer25-290
3×1CE; 1×GOL;
Assess
Crystal structure of D179Y KPC-2 beta-lactamase
7tbx
monomer24-289
Assess
Crystal structure of D179N KPC-2 beta-lactamase in complex with vaborbactam
7tc1
monomer25-289
1×4D6; 1×PO4;
Assess
Crystal structure of KPC-2 with compound 7
6mll
monomer25-289
1×N1G; 1×GOL;
Assess
Crystal structure of KPC-2 beta-lactamase in complex with the S02030 boronic acid inhibitor
5eec
monomer25-289
1×ZXM; 3×SO4;
Assess
KPC-2 N170A mutant bound to hydrolyzed imipenem at 2.05 A
6xj8
monomer26-290
1×8YF;
Assess
Crystal structure of KPC-2 beta-lactamase complexed with hydrolyzed EXW-1
7vqn
monomer25-289
4×SO4;
Assess
Crystal structure of D179N KPC-2 beta-lactamase
7tb7
monomer26-289
1×CIT;
Assess
Crystal structure of the C-terminal deleted mutant of the class A carbapenemase KPC-2 at 1.23 angst…
3c5a
monomer26-289
1×CIT;
Assess
KPC-2 carbapenemase in complex with PSR3-226
3rxw
monomer26-289
1×SR3; 1×CIT;
Assess
Crystal structure of KPC-2 with compound 9
6mey
monomer29-292
3×O5E; 1×ACT;
Assess
Crystal structure of KPC-2 S70G/T215P mutant with hydrolyzed imipenem
7lr9
monomer26-289
1×8YF;
Assess
Crystal structure of KPC-2 carbapenemase in complex with a phenyl boronic inhibitor.
5mgi
monomer26-289
1×6YV;
Assess
Crystal structure of the class A carbapenemase KPC-2 at 1.6 angstrom resolution
3dw0
monomer30-293
Assess
Crystal structure of KPC-2 S70G/T215P mutant with hydrolyzed meropenem
7llb
monomer26-289
1×8YL;
Assess
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
6j8q
monomer26-289
1×BHU; 7×PEG; 2×ACY;
Assess
Crystal structure of KPC-2 beta-lactamase complexed with avibactam
4zbe
monomer26-289
1×CIT; 1×NXL;
Assess
Crystal structure of KPC-2 S70G/T215P mutant with hydrolyzed imipenem
7lnl
monomer26-289
1×8YF;
Assess
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001
6jn4
monomer26-289
1×BX9; 1×ACT; 2×ACY; 2×PEG;
Assess
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS23
6jn5
monomer26-289
1×BXU;
Assess
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS05
6jn3
monomer26-289
1×BX6; 1×PEG; 2×ACY;
Assess
Crystal structure of KPC-2 in complex with (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)a…
7e9a
monomer26-289
1×J00; 1×ACY; 1×PEG; 3×GOL;
Assess
CRYSTAL STRUCTURE OF THE KPC-2 D179N VARIANT IN COMPLEX WITH RELEBACTAM (IMINE HYDROLYSIS INTERMEDI…
8g2t
monomer27-289
1×YOZ; 1×PO4;
Assess
CRYSTAL STRUCTURE OF THE KPC-2 D179N VARIANT IN COMPLEX WITH AVIBACTAM
8g2r
monomer26-288
1×NXL;
Assess
KPC-2 carbapenemase in complex with 3-NPBA
3rxx
monomer27-289
1×NPB;
Assess
Crystal structure of the deacylation deficient KPC-2 F72Y mutant
7ljk
monomer26-288
Assess
KPC-2 CARBAPENEMASE IN COMPLEX WITH THE BORONIC ACID INHIBITOR MB_076
7utb
monomer27-288
1×OC0;
Assess
Structure of KPC-2 bound to RPX-7063 at 1.75A
7ti2
monomer30-291
1×ZXQ; 2×EDO;
Assess
Crystal structure of the KPC-2 carbapenemase
2ov5
monomer30-290
1×BCN;
Assess
Crystal structure of KPC-2 T215P mutant
7lk8
monomer30-289
2×NA;
Assess
Crystal Structure of KPC-2 with compound 2
7u8s
monomer31-290
1×LW0;
Assess
KPC-2 F72Y mutant with acylated imipenem
7llh
monomer29-288
1×IM2;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6xd5.1.Amonomer0.9225-293
99.66
Assess